Lung metastasis from TTF-1 positive sigmoid adenocarcinoma. Pitfalls and management

Pathologica

Volumn 105, Issue 2, 2013, Pages 69-72

  Remo, A ^a   Zanella, C ^a   Pancione, M ^b   Astati, L ^a   Piacentini, P ^a   Cingarlini, S ^c   Bonetti, A ^a   Micheletto, C ^a   Talamini, A ^a   Chilosi, M ^c   Vendraminelli, R ^a   Manfrin, E ^c  

^a Mater Salutis Hospital   (Italy)

^b UNIVERSITY OF SANNIO   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Colorectal carcinoma; Lung metastasis; Molecular biology; TTF 1

Indexed keywords

DNA BINDING PROTEIN; TTF1 PROTEIN, HUMAN; TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; CASE REPORT; COLON TUMOR; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE EXPRESSION REGULATION; HUMAN; LUNG TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; SIGMOID;

ADENOCARCINOMA; COLON, SIGMOID; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; SIGMOID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84879242511     PISSN: 00312983     EISSN: 1591951X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Ordonez NG. Value of Thyroid Transcription Factor-1 Immunostaining in Tumor Diagnosis: A Review and Update. Appl Immuno-histochem Mol Morphol 2012;20:429-44.
2. Comperat E, Zhang F, Perrotin C, et al. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin. Mod Pathol 2005;18:1371-6. (Pubitemid 41348657)
3. Penman D, Downie I, Roberts F. Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution. J Clin Pathol 2006;59:663-4. (Pubitemid 43886055)
4. Matoso A, Singh K, Jacob R, et al. Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors. Appl Immunohistochem Mol Morphol 2010;18:142-9.
5. Ye J, Findeis-Hosey JJ, Yang Q, et al. Combination of Napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Appl Immunohistochem Mol Morphol 2011;19:313-7.
6. Xu B, Thong N, Tan D, et al. Expression of thyroid transcription factor-1 in colorectal carcinoma. Appl Immunohistochem Mol Morphol 2010;18:244-9.
7. Remo A, Pancione M, Zanella C, et al. Molecular pathology of colorectal carcinoma. A systematic review centred on the new role of pathologist. Pathologica 2012;104:432-41.
8. Pancione M, Remo A, Colantuoni V. Genetic and epigenetic events generate multiple pathways in colorectal cancer progression. Patholog Res Int 2012;2012:509348.
9. Watanabe T, Kobunai T,Yamamoto Y, et al. Heterogeneity of KRAS status may explain the subset of discordant KRAS status between primary and metastatic colorectal cancer. Dis Colon Rectum 2011;54:1170-8.
10. Messick CA, Church JM, Liu X, et al. Stage III colorectal cancer: molecular disparity between primary cancers and lymph node metastases. Ann Surg Oncol 2010;17:425-31.